Invitae ( Invitae)

Primary tabs

Invitae's picture

Management

Contact Address

About Invitae

Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.

Invitae press release, blog etc

Tue, 12/20/2022 - 08:51 Invitae Completes Selected Assets Sale of its Next Generation Sequencing (NGS) research assays to Integrated DNA Technologies, Inc.
Thu, 12/01/2022 - 10:20 Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases
Mon, 04/04/2022 - 08:51 Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders
Tue, 03/29/2022 - 07:15 Introducing Invitae Digital Health--A Personalized Health Management Platform That Leverages Genomic Insights to Inform Health Decisions for Patients and Clinicians
Wed, 03/16/2022 - 23:24 Invitae Launches Full Access to its Liquid-Based Personalized Cancer Monitoring Platform to Help Detect Disease Earlier
Mon, 03/14/2022 - 22:34 Invitae Publishes the 2022 Environmental, Social and Governance Report
Wed, 02/16/2022 - 16:11 Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
Thu, 02/03/2022 - 16:51 Invitae Supports the Biden Administration's Advancement of the Cancer Moonshot, Enhanced Recommendations on Genetic Testing for Cancer Treatment
Thu, 02/03/2022 - 15:45 Invitae to Present at Upcoming Investor Conferences
Sun, 01/09/2022 - 23:55 Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
Mon, 11/08/2021 - 02:09 Northwestern University and Invitae Present New Research Highlighting the Importance of Genetic Testing for Cardiovascular Conditions at the American Heart Association Scientific Sessions
Fri, 09/24/2021 - 21:26 New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
Tue, 09/07/2021 - 07:44 Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
Fri, 06/11/2021 - 12:49 Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
Thu, 06/03/2021 - 12:07 Invitae opens early access to liquid biopsy-based Personalized Cancer Monitoring as a central laboratory service
Tue, 05/25/2021 - 11:36 Germline genetic testing can benefit all cancer patients as a routine practice in cancer care
Tue, 04/20/2021 - 20:43 Invitae to Open New Facility in North Carolina to Support Continued Growth
Thu, 04/15/2021 - 07:49 Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancer
more

InfoBox

HomePagewww.invitae.com
Facebookwww.facebook.com/pages/Invitae/136602503165993
Twittertwitter.com/Invitae
LinkedInwww.linkedin.com/company/invitae